This area on the right buccal mucosa was biopsied and found to show typical features of oral lichen planus and no neoplasia. The patient was treated with three cryosurgery sessions. Same patient ...
no longer using "oral lichen planus" and vulvovaginal LP, but instead seeing this disease as an entity, mucosal LP. The men in this study generally had a shorter disease duration compared with ...
Lipella Pharmaceuticals shares were up 37% to $4.18 after the company said it saw positive topline results from its Phase 2a dose-ranging trial examining LP-310, a liposomal-tacrolimus oral rinse ...
Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...
Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company, Wednesday said that the U.S. Food and Drug ...
PITTSBURGH - Lipella Pharmaceuticals Inc. (NASDAQ:LIPO), a biotech firm specializing in novel therapies for medical conditions lacking adequate treatments, has received FDA approval for an Expanded ...
Oral lichen planus is a chronic inflammatory condition affecting the mucous membranes inside the mouth, often causing burning pain, white patches, swollen tissue and open sores. The condition impacts ...
an oral rinse formulated to treat oral lichen planus (OLP), a debilitating condition affecting around 6 million Americans with no approved treatments. LP-310 aims to provide targeted relief with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback